Regulated expression of platelet factor 4 in human monocytes--role of PARs as a quantitatively important monocyte

Andreas Schaffner1, Petra Rhyn, Gabriela Schoedon

  • 1Research Unit Medizinische Klinik B. University of Zurich, Switzerland.

Insights

Human monocytes express platelet factor 4 (PF4) and platelet basic protein (PBP), previously thought to be megakaryocyte-specific. Thrombin activation via proteinase-activated receptors (PARs) significantly upregulates these chemokines and others in monocytes.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Platelet basic protein (PBP) and platelet factor 4 (PF4) were traditionally considered specific markers for the megakaryocyte cell lineage.
  • Recent findings indicate that human mononuclear phagocytes express these CXC chemokines constitutively and upon stimulation.
  • Both PBP and PF4 possess signaling and antimicrobial activities.

Purpose of the Study:

  • To investigate the transcriptional and expressional regulation of PF4 and related chemokines in human monocytes.
  • To elucidate the role of proteinase-activated receptors (PARs) in monocyte chemokine expression.

Main Methods:

  • Quantitative mRNA analysis
  • Western blots
  • Radioimmunoprecipitation
  • Immunofluorescence
  • Enzyme-linked immunosorbent assay (ELISA)
  • Quantitative immunobead-based assays

Main Results:

  • Human monocytes express PF4 at levels comparable to interleukin-8 (IL-8).
  • Thrombin, acting through PARs, significantly upregulates PF4 mRNA (32-128 fold) and protein levels (up to 6-fold) in monocytes.
  • Thrombin and the PAR-1/PAR-2 ligand SFLLRN induce increased mRNA and synthesis of PBP, IL-8, RANTES, MCP-1, and MIP-1alpha.
  • SFLLRN-induced chemokine mRNA upregulation surpasses that induced by LPS, zymosan, IFN-gamma, TNF-alpha, and IL-1.

Conclusions:

  • Monocyte activation via PARs represents an alternative activation pathway, distinct from IFN-gamma, TNF-alpha, or other signaling routes.
  • PF4 and PBP are expressed and regulated in human monocytes, challenging their exclusive role as megakaryocyte markers.
  • PAR-mediated activation offers a novel mechanism for regulating inflammatory and antimicrobial chemokine expression in monocytes.